Marketing-authorisation holder · United States
Collegium Pharm Inc
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| NUCYNTA100mg base | 50mg base | 75mg base · Tablet | Tapentadol | United States | Marketed | 2008 |
| NUCYNTA20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Tapentadol | United States | Not marketed | 2012 |
| NUCYNTA ER100mg base | 150mg base | 200mg base | 250mg base | 50mg base · Tablet, extended release | Tapentadol | United States | Marketed | 2011 |
| XTAMPZA ER13.5mg | 18mg | 27mg | 36mg | 9mg · Capsule, extended release | Oxycodone | United States | Marketed | 2016 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 4 | 4 | 0 | CompaniesAll medicines |